{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:41:00Z","timestamp":1793032860577,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503815"],"award-info":[{"award-number":["82503815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100597","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:14:42Z","timestamp":1782976482000},"page":"100597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer"],"prefix":"10.1016","volume":"12","author":[{"given":"Haiwang","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijpx.2026.100597_bb0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","article-title":"CAF-induced physical constraints controlling T cell state and localization in solid tumours","volume":"24","author":"Arpinati","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"46","key":"10.1016\/j.ijpx.2026.100597_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi5790","article-title":"Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition","volume":"7","author":"Cascio","year":"2021","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.ijpx.2026.100597_bb0015","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1073\/pnas.1815515116","article-title":"Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpx.2026.100597_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122456","article-title":"Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis","volume":"305","author":"Chen","year":"2024","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0025","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","article-title":"Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer","volume":"15","author":"Croizer","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12943-025-02383-x","article-title":"IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1\/\u2212L1 therapy in SCLC","volume":"24","author":"Cui","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpx.2026.100597_bb0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.omto.2022.02.003","article-title":"Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer","volume":"24","author":"Ding","year":"2022","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.ijpx.2026.100597_bb0040","doi-asserted-by":"crossref","first-page":"1340634","DOI":"10.3389\/fimmu.2023.1340634","article-title":"Extracellular matrix remodeling in the tumor immunity","volume":"14","author":"Du","year":"2023","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.ijpx.2026.100597_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast cancer","volume":"25","author":"Dvir","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"2","key":"10.1016\/j.ijpx.2026.100597_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021321","article-title":"Emerging Roles of Hedgehog Signaling in Cancer Immunity","volume":"24","author":"Giammona","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13046-024-03138-0","article-title":"Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma","volume":"43","author":"Giammona","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijpx.2026.100597_bb0065","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2021.03.039","article-title":"Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis","volume":"333","author":"Gu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100597_bb0070","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/IJN.S442877","article-title":"Biomimetic nano-drug delivery system: an emerging platform for promoting tumor treatment","volume":"19","author":"Han","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"21","key":"10.1016\/j.ijpx.2026.100597_bb0075","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1158\/0008-5472.CAN-20-1723","article-title":"Hedgehog signaling regulates metabolism and polarization of mammary tumor-associated macrophages","volume":"81","author":"Hinshaw","year":"2021","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.ijpx.2026.100597_bb0080","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2174\/1389450119666180131105822","article-title":"Nanocarrier based advances in Drug delivery to Tumor: an Overview","volume":"19","author":"Jain","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"9","key":"10.1016\/j.ijpx.2026.100597_bb0085","article-title":"Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization","volume":"5","author":"Kumar","year":"2024","journal-title":"Cell Rep Med."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpx.2026.100597_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217133","article-title":"Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpx.2026.100597_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177994","article-title":"Bruceine D inhibits CAF-promoted angiogenesis of breast cancer via suppressing IL-6-mediated activation of the STAT3\/Notch1\/VEGFR2 axis","volume":"1003","author":"Ma","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ijpx.2026.100597_bb0110","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1158\/1078-0432.CCR-14-2110","article-title":"Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma","volume":"21","author":"Otsuka","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpx.2026.100597_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115259","article-title":"Recent progress in nanocarrier-based drug delivery systems for antitumour metastasis","volume":"252","author":"Peng","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijpx.2026.100597_bb0120","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1172\/JCI128644","article-title":"Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment","volume":"129","author":"Petty","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijpx.2026.100597_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146707","article-title":"Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function","volume":"6","author":"Petty","year":"2021","journal-title":"JCI Insight"},{"issue":"450","key":"10.1016\/j.ijpx.2026.100597_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3342","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.ijpx.2026.100597_bb0135","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1158\/1078-0432.CCR-20-3715","article-title":"Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer","volume":"27","author":"Steele","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"32","key":"10.1016\/j.ijpx.2026.100597_bb0140","doi-asserted-by":"crossref","first-page":"21077","DOI":"10.1021\/acsnano.4c02316","article-title":"Erythrocyte-mimicking nanovesicle targeting porphyromonas gingivalis for periodontitis","volume":"18","author":"Tang","year":"2024","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.ijpx.2026.100597_bb0145","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1158\/1078-0432.CCR-09-1913","article-title":"Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts","volume":"16","author":"Walter","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijpx.2026.100597_bb0150","doi-asserted-by":"crossref","first-page":"1171418","DOI":"10.3389\/fonc.2023.1171418","article-title":"The emerging roles of Hedgehog signaling in tumor immune microenvironment","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ijpx.2026.100597_bb0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.apsb.2019.01.011","article-title":"Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application","volume":"9","author":"Xia","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0160","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ijpx.2026.100597_bb0165","doi-asserted-by":"crossref","first-page":"19756","DOI":"10.1021\/acsnano.1c07180","article-title":"Cancer-erythrocyte hybrid membrane-camouflaged magnetic nanoparticles with enhanced photothermal-immunotherapy for ovarian cancer","volume":"15","author":"Xiong","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijpx.2026.100597_bb0170","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.clbc.2023.10.011","article-title":"Analysis of immune resistance mechanisms in TNBC: dual effects inside and outside the tumor","volume":"24","author":"Xu","year":"2024","journal-title":"Clin. Breast Cancer"},{"issue":"5","key":"10.1016\/j.ijpx.2026.100597_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051109","article-title":"Bioinspired and biomimetic nanomedicines for targeted cancer therapy","volume":"14","author":"Xu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100597_bb0180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.ijpx.2026.100597_bb0185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.apsb.2020.10.022","article-title":"Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpx.2026.100597_bb0190","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.2147\/IJN.S418100","article-title":"Co-delivery nanomicelles for potentiating TNBC immunotherapy by synergetically reshaping CAFs-mediated tumor stroma and reprogramming immunosuppressive microenvironment","volume":"18","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomedicine"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:13:05Z","timestamp":1793031185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S2590156726001179"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100597","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100597"}}